IMVT
Price
$37.36
Change
-$0.74 (-1.94%)
Updated
Sep 11 closing price
Capitalization
7.72B
67 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$11.39
Change
-$0.18 (-1.56%)
Updated
Sep 11 closing price
Capitalization
1.01B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs KURA

IMVT vs KURA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMVT vs. KURA commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a StrongBuy and KURA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($7.72B) has a higher market cap than KURA($1.01B). IMVT YTD gains are higher at: 46.971 vs. KURA (9.625). KURA has higher annual earnings (EBITDA): -293.98M vs. IMVT (-565.61M). IMVT has more cash in the bank: 798M vs. KURA (519M). IMVT has less debt than KURA: IMVT (72K) vs KURA (24.5M). KURA has higher revenues than IMVT: KURA (77.2M) vs IMVT (0).
IMVTKURAIMVT / KURA
Capitalization7.72B1.01B763%
EBITDA-565.61M-293.98M192%
Gain YTD46.9719.625488%
P/E RatioN/AN/A-
Revenue077.2M-
Total Cash798M519M154%
Total Debt72K24.5M0%
FUNDAMENTALS RATINGS
IMVT vs KURA: Fundamental Ratings
IMVT
KURA
OUTLOOK RATING
1..100
7391
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
49100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
3737
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMVT's Valuation (52) in the null industry is in the same range as KURA (64) in the Biotechnology industry. This means that IMVT’s stock grew similarly to KURA’s over the last 12 months.

IMVT's Profit vs Risk Rating (49) in the null industry is somewhat better than the same rating for KURA (100) in the Biotechnology industry. This means that IMVT’s stock grew somewhat faster than KURA’s over the last 12 months.

IMVT's SMR Rating (98) in the null industry is in the same range as KURA (99) in the Biotechnology industry. This means that IMVT’s stock grew similarly to KURA’s over the last 12 months.

IMVT's Price Growth Rating (37) in the null industry is in the same range as KURA (37) in the Biotechnology industry. This means that IMVT’s stock grew similarly to KURA’s over the last 12 months.

IMVT's P/E Growth Rating (100) in the null industry is in the same range as KURA (100) in the Biotechnology industry. This means that IMVT’s stock grew similarly to KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTKURA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (IMVT: $37.36 vs. KURA: $11.39)
Brand notoriety: IMVT and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 88% vs. KURA: 132%
Market capitalization -- IMVT: $7.72B vs. KURA: $1.01B
IMVT [@Biotechnology] is valued at $7.72B. KURA’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green while KURA’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 4 TA indicator(s) are bullish while KURA’s TA Score has 6 bullish TA indicator(s).

  • IMVT’s TA Score: 4 bullish, 5 bearish.
  • KURA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KURA is a better buy in the short-term than IMVT.

Price Growth

IMVT (@Biotechnology) experienced а -4.82% price change this week, while KURA (@Biotechnology) price change was -14.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

IMVT is expected to report earnings on Nov 18, 2026.

KURA is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IMVT
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRAAX64.280.67
+1.05%
Neuberger Quality Equity A
SEUIX30.65N/A
N/A
SEI Large Cap Value I (SIMT)
LGSCX16.08N/A
N/A
Franklin U.S. Small Cap Equity FI
JSJAX15.35N/A
N/A
JHancock Small Cap Dynamic Growth A
RERCX62.23-0.22
-0.35%
American Funds EUPAC R-3